Mhurchu C N, Anderson C, Jamrozik K, Hankey G, Dunbabin D
Clinical Trials Research Unit, University of Auckland (New Zealand).
Stroke. 2001 Mar;32(3):606-12. doi: 10.1161/01.str.32.3.606.
Subarachnoid hemorrhage (SAH) is more common in women than in men, but the role of hormonal factors in its etiology remains uncertain. The aim of this study was to examine the relationship between hormonal factors and risk of SAH in women.
This was a prospective, multicenter, population-based, case-control study performed in 4 major urban centers in Australia and New Zealand. Two hundred sixty-eight female cases of first-ever aneurysmal SAH occurred during 1995-1998. Controls were 286 frequency-matched women from the general population of each center. Outcome measures included risk of SAH associated with use of oral contraceptive pills (OCPs), hormone replacement therapy (HRT), and various endogenous hormonal factors including menstrual patterns, parity, age at birth of first child, and breast-feeding practices.
Cases and controls did not differ with regard to menstrual and reproductive history except in age at birth of first child, where older age was associated with reduced risk of SAH (odds ratio [OR], 0.63; 95% CI, 0.43, 0.91). Relative to never use of HRT, the adjusted OR for ever use of HRT was 0.64 (95% CI, 0.41, 0.98), which did not alter significantly after further adjustment for possible confounding factors. Borderline evidence of an inverse association was detected for past use of HRT (adjusted OR, 0.59; 95% CI, 0.30, 1.13) and current use of HRT (adjusted OR, 0.67; 95% CI, 0.40, 1.13), but there was no evidence of an association for use of OCPs (adjusted OR, 0.97; 95% CI, 0.58, 1.60).
The risks of SAH are lower in women whose first pregnancy is at an older age and women who have ever used HRT but not OCPs. The findings suggest an independent etiologic role for hormonal factors in the pathogenesis of aneurysmal SAH and provide support for a protective role for HRT on risk of SAH in postmenopausal women.
蛛网膜下腔出血(SAH)在女性中比男性更常见,但其病因中激素因素的作用仍不确定。本研究的目的是探讨激素因素与女性SAH风险之间的关系。
这是一项在澳大利亚和新西兰4个主要城市中心进行的前瞻性、多中心、基于人群的病例对照研究。1995年至1998年间发生了268例首次动脉瘤性SAH的女性病例。对照组是来自每个中心普通人群的286名频率匹配的女性。结局指标包括与口服避孕药(OCP)使用、激素替代疗法(HRT)以及各种内源性激素因素(包括月经模式、产次、第一个孩子出生时的年龄和母乳喂养习惯)相关的SAH风险。
病例组和对照组在月经和生殖史方面没有差异,只是在第一个孩子出生时的年龄方面,年龄较大与SAH风险降低相关(优势比[OR],0.63;95%可信区间,0.43,0.91)。相对于从未使用过HRT,曾经使用过HRT的调整后OR为0.64(95%可信区间,0.41,0.98),在对可能的混杂因素进行进一步调整后没有显著变化。对于过去使用HRT(调整后OR,0.59;95%可信区间,0.30,1.13)和当前使用HRT(调整后OR,0.67;95%可信区间,0.40,1.13)检测到反向关联的临界证据,但没有证据表明使用OCP与SAH有关联(调整后OR,0.97;95%可信区间,0.58,1.60)。
首次怀孕年龄较大的女性以及曾经使用过HRT但未使用OCP的女性发生SAH的风险较低。这些发现表明激素因素在动脉瘤性SAH的发病机制中具有独立的病因学作用,并为HRT对绝经后女性SAH风险的保护作用提供了支持。